পদ্ধতির তুলনা করুন

	স্বাস্থ্য অর্থনীতিতে সিদ্ধান্ত বিশ্লেষণমূলক মডেলিং	ব্যয়-কার্যকারিতা বিশ্লেষণ (CEA)
ক্ষেত্র	স্বাস্থ্য অর্থনীতি	স্বাস্থ্য অর্থনীতি
পরিবার	Process / pipeline	Process / pipeline
উদ্ভবের বছর	1975	1984
প্রবর্তক	Pauker & Kassirer (medical decision analysis, Massachusetts General Hospital)	Drummond & Stoddart (Health Economics Research Group, McMaster University)
ধরন	Method	Method
মৌলিক উৎস	Pauker, S. G., & Kassirer, J. P. (1975). Therapeutic Decision Making: A Cost-Benefit Analysis. New England Journal of Medicine, 293(5), 229-234.	Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (Eds.). (1996). Cost-Effectiveness in Health and Medicine. New York: Oxford University Press.
অপর নাম	decision analysis, decision tree, decision model, health economic model	CEA, ICER, Incremental Cost-Effectiveness Ratio
সম্পর্কিত	5	5
সারসংক্ষেপ	Decision analytic modeling is a systematic framework for comparing health interventions by integrating evidence on probabilities, outcomes, costs, and patient preferences into a quantitative model. Developed by Pauker and Kassirer in 1975, decision analysis structures clinical uncertainty and economic trade-offs, enabling transparent comparison of treatment options and identification of optimal strategies. Used in health technology assessment, clinical practice guideline development, and resource allocation decisions.	Cost-effectiveness analysis compares the incremental cost per unit of health benefit gained by one intervention relative to a comparator (standard care or best alternative). Developed rigorously in the 1980s by Drummond, Stoddart, and colleagues, CEA is now the standard framework for technology appraisal globally. NICE, HAS, CADTH, and other health technology assessment bodies use CEA to decide which treatments warrant public funding and at what price.